The inaugural Microbiome World Congress Americas 2017 will bring together leading pharma, biotechs, academic researchers, and their partners to Washington DC in order to discuss how to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products.


Leading the discussion at our 2017 event includes: ‚Äč

  • Jack Gilbert,  Faculty Director,  The Microbiome Center,  Professor, Department of Surgery,  The University of Chicago  , Senior Scientist (Adjunct),  the Marine Biological Laboratory  , Group Leader in Microbial Ecology,  Argonne National Laboratory 

  • Carrie Brodmerkel,  Director of Immunology Biomarkers,  Janssen

  • Nikola Trbovic,  PhD, Director R &D Technology Strategy,  Pfizer

  • Paul E. Carlson Jr.,  PhD, Principal investigator, Laboratory of Mucosal Pathogens and Cellular Immunology, CBER/OVRR,  U.S. Food and Drug Administration

  • Kathleen Basmadjian,  Senior Director, Global Regulatory Policy & Intelligence, Global Regulatory Affairs,  Janssen R & D

  • Jim Brown,  Director, Computational Biology, Senior Fellow,  GlaxoSmithKline

  • Matt Henn,  Senior VP, Head of Drug Discovery and Bioinformatics,  Seres Therapeutics

  • Elaine Hsiao,  PhD, Assistant Professor, Department of Integrative Biology & Physiology,  UCLA

  • and 50+ industry leaders.  Click here to see the full speaker list >>